Opsens Agrees to Sell Itself to U.S.-Based Haemonetics in C$345M Deal Markets – MarketWatch

Posted on October 10, 2023 by

By Adriano Marchese Opsens said Tuesday that it has agreed to be acquired by healthcare company Haemonetics in a deal worth 345 million Canadian dollars, or…

Markets – MarketWatch

Posted in Finance

Previous: Lockheed Martin, Other Defense Stocks Tick Higher Amid Middle East Violence Markets – MarketWatch

Next: PepsiCo’s stock up premarket after earnings beat consensus and company raises guidance Markets – MarketWatch

Finance

Here are the S&P 500 and Nasdaq 100 companies that had consistently high returns on equity for at least 10 years Markets – MarketWatch

October 16, 2023
0

What’s a good starting point when looking for companies that have a good moat? […]

Finance

Startek Shares Leap on Deal to be Taken Private Markets – MarketWatch

October 10, 2023
0

By Colin Kellaher Shares of Startek surged by nearly 30% in early trading Tuesday […]

Finance

Communications Services Up on Growth Hopes — Communications Services Roundup Markets – MarketWatch

October 11, 2023
0

Communications services companies rose as traders increased their exposure to higher risk niches of […]

Related Posts

Here are the S&P 500 and Nasdaq 100 companies that had consistently high returns on equity for at least 10 years Markets – MarketWatch

Startek Shares Leap on Deal to be Taken Private Markets – MarketWatch

Communications Services Up on Growth Hopes — Communications Services Roundup Markets – MarketWatch